Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Thermo Fisher Scientific Inc
TMO
$480.05
Name : Thermo Fisher Scientific Inc
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $178,331,009,024.00
EPSttm : 17.75
finviz dynamic chart for TMO
Thermo Fisher Scientific Inc
$480.05
1.41%
$6.69
TMO — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

1.05

Margin Of Safety %

9

Put/Call OI Ratio

1.45

EPS Next Q Diff

3.93

EPS Last/This Y

1.65

EPS This/Next Y

2.37

Price

473.36

Target Price

662.04

Analyst Recom

1.41

Performance Q

-18.24

Upside

-17.6%

Beta

0.97

Ticker: TMO




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-02TMO508.341.436.8754512
2026-03-03TMO508.061.483.0656175
2026-03-04TMO512.771.485.6157044
2026-03-05TMO518.991.475.1058321
2026-03-06TMO501.741.461.2658678
2026-03-09TMO510.011.520.5656168
2026-03-10TMO500.291.511.8256568
2026-03-11TMO495.831.520.7357010
2026-03-12TMO475.751.500.6557918
2026-03-13TMO475.891.500.7157918
2026-03-17TMO472.781.2418.2155498
2026-03-18TMO464.851.1615.3754685
2026-03-19TMO470.221.1530.0654973
2026-03-20TMO474.661.140.8655747
2026-03-23TMO478.21.240.4143219
2026-03-24TMO490.251.217.7943817
2026-03-25TMO490.761.403.7948027
2026-03-26TMO488.891.460.4849670
2026-03-27TMO473.351.451.3049992
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-02TMO508.252.71342.624.54
2026-03-03TMO508.082.71549.224.54
2026-03-04TMO512.782.71637.824.54
2026-03-05TMO518.932.71663.724.54
2026-03-06TMO502.032.71274.424.54
2026-03-09TMO510.072.71437.624.54
2026-03-10TMO500.022.71128.324.54
2026-03-11TMO495.732.51222.524.53
2026-03-12TMO475.782.5949.924.53
2026-03-13TMO464.182.51094.224.52
2026-03-17TMO472.702.51347.024.52
2026-03-18TMO464.752.51153.124.52
2026-03-19TMO470.202.5591.524.52
2026-03-20TMO474.392.5570.224.52
2026-03-23TMO478.282.5562.924.52
2026-03-24TMO490.292.5699.624.52
2026-03-25TMO490.762.5505.624.52
2026-03-26TMO489.022.5469.724.52
2026-03-27TMO473.362.5246.424.52
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-02TMO-19.551.440.96
2026-03-03TMO-19.511.440.96
2026-03-04TMO-19.511.440.96
2026-03-05TMO-20.521.440.96
2026-03-06TMO-20.521.440.96
2026-03-09TMO-20.881.440.96
2026-03-10TMO-20.881.440.96
2026-03-11TMO-20.881.440.96
2026-03-12TMO-21.041.440.96
2026-03-13TMO-21.041.440.96
2026-03-17TMO-21.041.460.96
2026-03-18TMO-21.041.460.96
2026-03-19TMO-21.041.460.96
2026-03-20TMO-21.041.460.96
2026-03-23TMO-21.041.490.96
2026-03-24TMO-21.041.490.96
2026-03-25TMO-21.041.491.05
2026-03-26TMO-21.041.491.05
2026-03-27TMO-21.041.491.05
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

1.87

Avg. EPS Est. Current Quarter

5.28

Avg. EPS Est. Next Quarter

5.8

Insider Transactions

-21.04

Institutional Transactions

1.49

Beta

0.97

Average Sales Estimate Current Quarter

10866

Average Sales Estimate Next Quarter

11479

Fair Value

515.69

Quality Score

80

Growth Score

78

Sentiment Score

95

Actual DrawDown %

29.6

Max Drawdown 5-Year %

-41

Target Price

662.04

P/E

26.69

Forward P/E

17.65

PEG

1.93

P/S

3.95

P/B

3.34

P/Free Cash Flow

27.95

EPS

17.74

Average EPS Est. Cur. Y​

24.52

EPS Next Y. (Est.)

26.89

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

15.05

Relative Volume

0.71

Return on Equity vs Sector %

-14.8

Return on Equity vs Industry %

1.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

246.4
TMO Healthcare
$473.46
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
12/25
Volume
9/15
Valuation
20/20
TP/AR
4/10
Options
1/10
RSI
37
Range 1M
24%
🚀
Momentum Growth
Ride accelerating trends
N/A
34 /100
WEAK
Momentum
8/25
Growth
13/30
Estimates
7/20
Inst/Vol
3/15
Options
3/10
EPS Yr
7.4%
EPS NY
9.2%
52W%
34%
💎
Long-Term Value
Quality companies, undervalued
43 /100
WEAK
🟡 HOLD +23.1% upside
Quality
11/30
Valuation
11/30
Growth
11/25
Stability
7/10
LT Trend
3/5
Upside
+23.1%
Quality
80
MoS
9%
Thermo Fisher Scientific Inc
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 125000
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
TMO

Latest News

Caricamento notizie per TMO
stock quote shares TMO – Thermo Fisher Scientific Inc. Stock Price stock today
news today TMO – Thermo Fisher Scientific Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch TMO – Thermo Fisher Scientific Inc. yahoo finance google finance
stock history TMO – Thermo Fisher Scientific Inc. invest stock market
stock prices TMO premarket after hours
ticker TMO fair value insiders trading